Electrophysiological indices of information processing in methylphenidate responders

Personalized Medicine: Review and Perspectives of Promising Baseline EEG Biomarkers in Major Depressive Disorder and Attention Deficit Hyperactivity Disorder

“…Within this subgroup, poor responders to imipramine demonstrated slower P3 latencies [159]. Sunohara et al [160 ]could not replicate ERP P3 and N2 latencies as baseline predictors for treatment outcome in ADHD children but found some treatment-emergent effects which are in agreement with Winsberg et al [161]. …”

Heritability of anterior and posterior visual N1

“…Smith et al (2004) also reported reduced N1 amplitude in ADHD using a go/no-go task. By contrast, several other studies reported no significant group differences for amplitude in the N1 time range (Rothenberger et al, 2000;Winsberg et al, 1997). It is possible that more consistent effects may be found in the 'processing negativity', which is the negative shift seen in a selective attention task by comparing ERPs of stimuli from the attended to those of the unattended channel, appearing in a time range covering the N1, P1 and N2 (Altenmüller and Gerloff, 1999).…”

“…In the auditory domain the N1 peaks at the vertex (Cz), whereas in the visual domain two main negative peaks can be found: an early anterior N1, and a somewhat later posterior N1 (Vogel and Luck, 2000). The N1 peak amplitude and latency have been studied widely to investigate individual differences in disease susceptibility (e.g., Olbrich et al, 2000;Winsberg et al, 1997).…”

Mismatch Negativity: Clinical and Other Applications

“…Cochlear implants [Ponton et al, 2000] Psychiatry Schizophrenia [Shelley et al, 1991] Children at risk for schizophrenia [Schreiber et al, 1992] Depression [Ogura et al, 1993] Somatization [James et al, 1989] Alcoholism [Ahveninen et al, in press] Children at risk for alcoholism [Rodriquez Holguin et al, 1998] Neurology Aging [Pekkonen et al, 1993] Alzheimer's disease [Pekkonen et al, 1994] Parkinson's disease HIV [Schröder et al, 1994] Sleep [Atienza et al, 1997] Coma (monitoring and prognosis) [Kane et al, 1993] Frontal-lobe damage [Alho et al, 1994] Thalamic infarctions [Mäkelä et al, 1998] Diabetes mellitus [Vanhanen et al, 1996] Neglect and auditory extinction [Deouell et al, 2000] Other Anesthesia [Csepe et al, 1989] Drug effects Alcohol [Jääskeläinen et al, 1995] Antihistamine [Serra et al, 1996] Cholecystokinin [Schreiber et al, 1995] Flumazenil [Smolnik et al, 1998] Methylphenidate [Winsberg et al, 1997] Naltrexone [Jääskeläinen et al, 1998] NMDA [Javitt et al, 1996] Tacrine [Riekkinen et al, 1997] Triazolam [Nakagome et al, 1998] Vasopressin ] Clozapine [Umbricht et al, 1998] Learning Native language [Cheour et al, 1998a] Foreign language ] Musicality Noise effects [Shtyrov et al, 1999] Hypnosis [Kallio et al, 1999] …”